Who Buys Valsartan from India — 663 Importers Behind a $196.9M Market
India's valsartan import market is served by 663 active buyers who collectively imported $196.9M across 6,098 shipments. MYLAN PHARMACEUTICALS INC, (UNITED STATES) leads with a 19.1% market share, followed by MACLEODS PHARMA USA ,INC and MACLEODS PHARMA USA,INC. The top 5 buyers together control 40.7% of total import value, reflecting a moderately competitive buyer landscape.
Top Valsartan Importers — Ranked by Import Value
MYLAN PHARMACEUTICALS INC, (UNITED STATES) is the leading valsartan importer from India, holding a 19.1% share of the $196.9M market across 6,098 shipments from 663 buyers. The top 5 buyers — MYLAN PHARMACEUTICALS INC, (UNITED STATES), MACLEODS PHARMA USA ,INC (UNITED STATES), MACLEODS PHARMA USA,INC (UNITED STATES), NEXTPHARMA LOGISTICS GMBH (GERMANY), MYLAN PHARMACEUTICALS INC (UNITED STATES) — collectively control 40.7% of total import value.
Top Valsartan Buyers & Importers
Ranked by import value · 663 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | MYLAN PHARMACEUTICALS INC,UNITED STATES VALSARTAN TABLETS USP 160 MG 90BT TAB 52200 PACKSVALSARTAN TABLETS USP 80 MG 90BT TAB 51660 PACKSVALSARTAN TABLETS USP 320 MG 90BT TAB PACKS 12936 | $37.5M | 5 | 19.1% |
| 2 | MACLEODS PHARMA USA ,INCUNITED STATES VALSARTAN TABLETS USP 160 MG 90BT TAB 52200 PACKSVALSARTAN TABLETS USP 80 MG 90BT TAB 51660 PACKSVALSARTAN TABLETS USP 320 MG 90BT TAB PACKS 12936 | $13.1M | 5 | 6.7% |
| 3 | MACLEODS PHARMA USA,INCUNITED STATES VALSARTAN TABLETS USP 160 MG 90BT TAB 52200 PACKSVALSARTAN TABLETS USP 80 MG 90BT TAB 51660 PACKSVALSARTAN TABLETS USP 320 MG 90BT TAB PACKS 12936 | $11.9M | 5 | 6.1% |
| 4 | NEXTPHARMA LOGISTICS GMBHGERMANY AMLO/VALS/HCT BETA 10/160/25MG FTB 98 DEPS:7X14S189974, VALSARTAN 160 MG FT FASS H, BATCAMLO/VALS/HCT BETA 10/320/25MG FTB 98 DE PACK SIZE-7X14 | $9.1M | 5 | 4.6% |
| 5 | MYLAN PHARMACEUTICALS INCUNITED STATES VALSARTAN TABLETS USP 160 MG 90BT TAB 52200 PACKSVALSARTAN TABLETS USP 80 MG 90BT TAB 51660 PACKSVALSARTAN TABLETS USP 320 MG 90BT TAB PACKS 12936 | $8.4M | 5 | 4.3% |
| 6 | LEK D.DSLOVENIA VALSARTAN FCT 160MG IN91 SH EU 03 MATERIVALSARTAN FCT 160MG IN91 SH EU 03 MATERIAL NO. - 42029820VALSARTAN AND HYDROCHLOROTHIAZIDE | $6.9M | 5 | 3.5% |
| 7 | MYLAN HUNGARY KFT,HUNGARY VALSARTAN TABLETS USP 160 MG 90BT TAB 52200 PACKSVALSARTAN TABLETS USP 80 MG 90BT TAB 51660 PACKSVALSARTAN TABLETS USP 320 MG 90BT TAB PACKS 12936 | $4.7M | 5 | 2.4% |
| 8 | YUSEN LOGISTICS BENELUX BELGIUMBELGIUM VALSARTAN TABLETS 160MG ( VALSARTAN BASIVALSARTAN TABLETS 80MG ( VALSARTAN BASIC | $4.5M | 5 | 2.3% |
| 9 | M/S. MYLAN PHARMACEUTICALS INC,UNITED STATES AMLO/VALS/HCT BETA 10/160/25MG FTB 98 DEPS:7X14SVALSARTAN AND HYDROCHLOROTHIAZIDE TABLETVALSARTAN TABLETS 160 MG | $4.5M | 5 | 2.3% |
| 10 | J. KNIPPER & COMPANYUNITED STATES VALSARTAN TABLETS USP 160 MG 90BT TAB 52200 PACKSVALSARTAN TABLETS USP 80 MG 90BT TAB 51660 PACKSVALSARTAN TABLETS USP 320 MG 90BT TAB PACKS 12936 | $4.4M | 5 | 2.2% |
| 11 | DR. REDDYS LABORATORIES, INCUNITED STATES VALSARTAN TABLETS USP 160 MG 90BT TAB 52200 PACKSVALSARTAN TABLETS USP 80 MG 90BT TAB 51660 PACKSVALSARTAN TABLETS USP 320 MG 90BT TAB PACKS 12936 | $4.0M | 5 | 2.0% |
| 12 | MACLEODS PHARMA USA INCUNITED STATES VALSARTAN TABLETS USP 160 MG 90BT TAB 52200 PACKSVALSARTAN TABLETS USP 80 MG 90BT TAB 51660 PACKSVALSARTAN TABLETS USP 320 MG 90BT TAB PACKS 12936 | $3.8M | 5 | 1.9% |
| 13 | ELARA PHARMASERVICES LIMITEDUNITED KINGDOM VALSARTAN 80 MG CAPS 4X7 JUB UK ELARA,VALSARTAN 40 MG CAPS 4X7 JUB UK ELARA, | $3.3M | 5 | 1.7% |
| 14 | KAWKAB SCIENTIFIC BUREAU*IRAQ | $2.4M | 5 | 1.2% |
| 15 | J KNIPPER COMPANYUNITED STATES VALSARTAN TABLETS USP 160 MG 90BT TAB 52200 PACKSVALSARTAN TABLETS USP 80 MG 90BT TAB 51660 PACKSVALSARTAN TABLETS USP 320 MG 90BT TAB PACKS 12936 | $2.4M | 5 | 1.2% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Valsartan — and from which countries?
Flow of Valsartan exports from India: each country's share and the named importers behind the numbers
Valsartan — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $119.8M through 676 shipments. This represents a market share of 60.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• MYLAN PHARMACEUTICALS INC, - $37.5M (31.3% of country's total business)
• MACLEODS PHARMA USA ,INC - $13.1M (10.9% of country's total business)
• MACLEODS PHARMA USA,INC - $11.9M (10.0% of country's total business)
• MYLAN PHARMACEUTICALS INC - $8.4M (7.0% of country's total business)
• M/S. MYLAN PHARMACEUTICALS INC, - $4.5M (3.7% of country's total business)
• Rest of United States's importers - $44.3M (37.0% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $177.2K, indicating premium pricing strategy compared to the market average of $32.3K.
United States is a key market for Valsartan imports, representing 60.8% of total trade value.
2Germany
Germany emerges as the second largest importing country, achieving a total trade value of $12.3M through 11 shipments. This represents a market share of 6.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Germany has a diverse importer base, with their top importers including:
• NEXTPHARMA LOGISTICS GMBH - $9.1M (74.5% of country's total business)
Key Insight: Germany demonstrates strong market positioning with an average shipment value of $1.1M, indicating premium pricing strategy compared to the market average of $32.3K.
Germany is a key market for Valsartan imports, representing 6.2% of total trade value.
3Slovenia
Slovenia emerges as the third largest importing country, achieving a total trade value of $9.6M through 67 shipments. This represents a market share of 4.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Slovenia has a diverse importer base, with their top importers including:
• LEK D.D - $6.9M (71.4% of country's total business)
Key Insight: Slovenia demonstrates strong market positioning with an average shipment value of $143.7K, indicating premium pricing strategy compared to the market average of $32.3K.
Slovenia is a key market for Valsartan imports, representing 4.9% of total trade value.
4Hungary
Hungary emerges as the fourth largest importing country, achieving a total trade value of $7.1M through 90 shipments. This represents a market share of 3.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Hungary has a diverse importer base, with their top importers including:
• MYLAN HUNGARY KFT, - $4.7M (66.8% of country's total business)
Key Insight: Hungary demonstrates strong market positioning with an average shipment value of $78.6K, indicating premium pricing strategy compared to the market average of $32.3K.
Hungary is a key market for Valsartan imports, representing 3.6% of total trade value.
5Iraq
Iraq emerges as the fifth largest importing country, achieving a total trade value of $6.7M through 78 shipments. This represents a market share of 3.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Iraq has a diverse importer base, with their top importers including:
• KAWKAB SCIENTIFIC BUREAU* - $2.4M (36.2% of country's total business)
Key Insight: Iraq demonstrates strong market positioning with an average shipment value of $85.5K, indicating premium pricing strategy compared to the market average of $32.3K.
Iraq is a key market for Valsartan imports, representing 3.4% of total trade value.
Buyer Segment Analysis
TransData Nexus Valsartan buyer market intelligence
1Buyer Segment Analysis
The importation of Valsartan from India involves various buyer segments, each with distinct purchasing behaviors:
1. Pharmaceutical Manufacturers: Entities like MYLAN PHARMACEUTICALS INC and MACLEODS PHARMA USA, INC, both based in the United States, procure Valsartan as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their purchasing patterns are characterized by large-volume orders to meet continuous production demands, ensuring a steady supply chain for their antihypertensive product lines.
2. Distributors and Logistics Companies: Organizations such as NEXTPHARMA LOGISTICS GMBH in Germany and YUSEN LOGISTICS BENELUX BELGIUM function as intermediaries, facilitating the distribution of Valsartan to various healthcare providers and retailers. Their procurement is typically aligned with market demand forecasts, leading to variable order sizes and frequencies.
3. Contract Manufacturers: Companies like LEK D.D in Slovenia and MYLAN HUNGARY KFT in Hungary operate as contract manufacturers, producing Valsartan-based medications for other pharmaceutical firms. Their purchasing behavior is project-based, with order volumes and schedules dictated by contractual agreements with their clients.
Understanding these segments is crucial for tailoring supply chain strategies and meeting the specific needs of each buyer category.
Country-Specific Import Regulations
TransData Nexus Valsartan buyer market intelligence
1Country-Specific Import Regulations
Import regulations for Valsartan vary across the top importing countries:
1. United States:
2. Germany:
3. Slovenia:
4. Hungary:
5. Iraq:
Compliance with these country-specific regulations is essential for market entry and sustained operations.
Demand Drivers & Market Opportunity
TransData Nexus Valsartan buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Valsartan in importing countries is influenced by several factors:
1. Prevalence of Hypertension: Hypertension is a leading risk factor for cardiovascular diseases globally. The World Health Organization (WHO) reports that approximately 1.13 billion people worldwide have hypertension, with a significant proportion residing in low- and middle-income countries. This high prevalence drives the demand for antihypertensive medications like Valsartan.
2. Government Healthcare Programs and Universal Health Coverage (UHC): Many countries are expanding their healthcare programs to achieve UHC, increasing access to essential medicines. For instance, the WHO's Model List of Essential Medicines includes Valsartan, guiding countries in their procurement decisions to ensure the availability of critical medications.
3. Tender-Based Purchasing: Public procurement agencies often utilize tendering processes to acquire medicines cost-effectively. A 2023 WHO workshop highlighted that tendering and negotiation are key strategies in pharmaceutical pricing policies, aiming to ensure the availability and affordability of essential medicines. (cdn.who.int)
With 663 buyers across 119 countries, the global reach of Valsartan underscores its critical role in managing hypertension and the opportunities for suppliers to meet this widespread demand.
Common Questions — Valsartan Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest valsartan buyer importing from India?
Based on import volume and value, MYLAN PHARMACEUTICALS INC, (UNITED STATES) leads with $37.5M in imports and a 19.1% market share — the highest of any single valsartan importer. MACLEODS PHARMA USA ,INC (UNITED STATES) and MACLEODS PHARMA USA,INC (UNITED STATES) are the next largest buyers.
QHow many companies buy valsartan from India?
There are 663 active valsartan buyers importing from India, with a combined market of $196.9M across 6,098 shipments to 119 countries. The top 5 buyers hold 40.7% of total import value, while the remaining 658 buyers handle the other 59.3%.
QWhich countries import the most valsartan from India?
The top importing countries for valsartan from India are United States (60.8%), Germany (6.2%), Slovenia (4.9%), Hungary (3.6%), Iraq (3.4%). These markets represent the largest demand centres for Indian pharmaceutical exports of valsartan, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for valsartan from India?
The average import transaction value for valsartan from India is $32.3K, with an average unit price of $8.45 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Valsartan buyer market intelligence
1Buyer Segment Analysis
The importation of Valsartan from India involves various buyer segments, each with distinct purchasing behaviors:
1. Pharmaceutical Manufacturers: Entities like MYLAN PHARMACEUTICALS INC and MACLEODS PHARMA USA, INC, both based in the United States, procure Valsartan as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their purchasing patterns are characterized by large-volume orders to meet continuous production demands, ensuring a steady supply chain for their antihypertensive product lines.
2. Distributors and Logistics Companies: Organizations such as NEXTPHARMA LOGISTICS GMBH in Germany and YUSEN LOGISTICS BENELUX BELGIUM function as intermediaries, facilitating the distribution of Valsartan to various healthcare providers and retailers. Their procurement is typically aligned with market demand forecasts, leading to variable order sizes and frequencies.
3. Contract Manufacturers: Companies like LEK D.D in Slovenia and MYLAN HUNGARY KFT in Hungary operate as contract manufacturers, producing Valsartan-based medications for other pharmaceutical firms. Their purchasing behavior is project-based, with order volumes and schedules dictated by contractual agreements with their clients.
Understanding these segments is crucial for tailoring supply chain strategies and meeting the specific needs of each buyer category.
Country-Specific Import Regulations
TransData Nexus Valsartan buyer market intelligence
1Country-Specific Import Regulations
Import regulations for Valsartan vary across the top importing countries:
1. United States:
2. Germany:
3. Slovenia:
4. Hungary:
5. Iraq:
Compliance with these country-specific regulations is essential for market entry and sustained operations.
Demand Drivers & Market Opportunity
TransData Nexus Valsartan buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Valsartan in importing countries is influenced by several factors:
1. Prevalence of Hypertension: Hypertension is a leading risk factor for cardiovascular diseases globally. The World Health Organization (WHO) reports that approximately 1.13 billion people worldwide have hypertension, with a significant proportion residing in low- and middle-income countries. This high prevalence drives the demand for antihypertensive medications like Valsartan.
2. Government Healthcare Programs and Universal Health Coverage (UHC): Many countries are expanding their healthcare programs to achieve UHC, increasing access to essential medicines. For instance, the WHO's Model List of Essential Medicines includes Valsartan, guiding countries in their procurement decisions to ensure the availability of critical medications.
3. Tender-Based Purchasing: Public procurement agencies often utilize tendering processes to acquire medicines cost-effectively. A 2023 WHO workshop highlighted that tendering and negotiation are key strategies in pharmaceutical pricing policies, aiming to ensure the availability and affordability of essential medicines. (cdn.who.int)
With 663 buyers across 119 countries, the global reach of Valsartan underscores its critical role in managing hypertension and the opportunities for suppliers to meet this widespread demand.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 663 global importers of Valsartan identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 6,098 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 119 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
6,098 Verified Shipments
663 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists